Streaks Gaming PLC, the developer of a conversational gaming platform tapping into the fast-growing US sports betting market, has raised £3 million as part of its initial public offering in London, with the majority invested by AQRU PLC (AQSE:AQRU).
AQRU, a decentralized finance incubator, has bought £2.3m worth of shares, which were priced at 3p each.
Shares in Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) rose on Wednesday after the company disclosed that the US medical regulator had given the green light for its combination product XENOVIEW drug device.
The US Food and Drug Administration (FDA) granted approval for use of XENOVIEW in the evaluation of pulmonary ventilation in adults and children aged 12 years and older, the company said, with its scanning software and chest coil devices also granted approval to support a successful launch of the technology in the clinical marketplace.
Argo Blockchain PLC (LSE:ARB, OTCQX:ARBKF, NASDAQ:ARBK, ETR:0XP) told investors it has agreed to sell its Texas-based Helios blockchain mining facility for $65m (£54m) to Galaxy Digital (TSX-V) :GLXY) and now has a “renewed focus” on its Canadian operations.
The cryptocurrency miner said it has also refinanced its asset-backed loans with a new $35 million loan from Galaxy with a three-year term.
Applied Graphene Materials PLC (AIM:AGM, OTCQX:APGMF) has said it is in talks with a number of “interested parties” who have made non-binding proposals since it launched a strategic review in November this year.
The board, in conjunction with advisers Alvarez & Marsal, who were appointed to manage the review, are said to be in discussions with the parties with a view to producing final proposals early next month and reducing this to a preferred transaction to be completed.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF), the fully integrated commercial biotechnology company specializing in allergy vaccines, has announced that Scott Leinenweber has resigned as a non-executive director of the group with immediate effect. The company said the board wanted to thank him for his valued contribution during his tenure.
Anglesey Mining PLC (AIM:AYM) has announced that Howard Miller, a non-executive director of the company, has passed away after a short illness on 22 December 2022. Miller had been a non-executive director of Anglesey since 2001, serving as the lead independent director from 2013 until his death. Speaking on behalf of the board, the company’s chairman, John Kearney, said: “Howard had a wealth of knowledge and experience across all legal, financial and management areas and provided wise counsel and sound advice to the Anglesey board and the company’s management. We offer our sincere condolences to Howard’s wife, children and family. He will be sadly missed.”
Plexus Holdings PLC (AIM:POS), the AIM-listed oil and gas engineering services business, has announced that each of the resolutions proposed at the Annual General Meeting (AGM) was duly passed by a show of hands without a vote being taken. demanded. On 20 October 2022, the company announced that it had raised £1,550,000 through the issue of 1,550,000 convertible loan notes to each of OFM Investment Limited (an entity linked to the van Bilderbeek family), Ben van Bilderbeek, CEO of Plexus, and Jeff Thrall , non-executive director of Plexus, under the terms of a loan note instrument. Following the adoption of the resolutions at the general meeting, the company is now authorized to enter into the debenture with Ben van Bilderbeek and has done so with effect from the date of the general meeting.
Advanced Oncotherapy PLC (AIM:AVO), the developer of LIGHT, the next-generation proton therapy system for cancer treatment, has announced that on 23 December 2022 Dr Michael Sinclair, its executive chairman, acquired a total of 80,000 ordinary shares of 25p each in the company at a price of 12.3p per share. Following this purchase, Dr Sinclair has a total beneficial interest in 9,440,814 ordinary shares corresponding to 1.76% of the company’s issued share capital.
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) said it has received A$800,000 (£450,000) in funding to be used as working capital to fund ongoing operations, including its clinical trials programme. The funds were drawn from its US$10 million convertible securities financing facility agreed with US institutional fund manager Mercer Street Capital. Under the terms of the facility, the plant-based pharmaceutical company will issue 586,432 convertible notes with a par value of $1.00 each to Mercer.
Diversified Energy Company PLC (LSE:DEC, OTCQX:DECPF) has appointed Kathryn Klaber as an independent non-executive director effective January 1, 2023. The appointment is part of the previously announced transition of current board member Melanie Little, and maintains the size on the board of eight members, and diversity composition including 63% independent and 37% female board members. Klaber’s more than 30 years of experience focuses on energy development and environmental, health and safety compliance, with Klaber Group’s strategic consulting firm offering services to companies and organizations with a focus on energy development in the US and abroad.
